Pro Share Advisors LLC Arvinas, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 16,196 shares of ARVN stock, worth $309,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,196
Previous 10,980 47.5%
Holding current value
$309,019
Previous $292,000 36.3%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$23.66 - $32.73 $123,410 - $170,719
5,216 Added 47.5%
16,196 $398,000
Q2 2024

Aug 13, 2024
SELL
$24.46 - $40.4 $69,759 - $115,220
-2,852 Reduced 20.62%
10,980 $292,000
Q1 2024

May 08, 2024
BUY
$36.38 - $52.31 $79,599 - $114,454
2,188 Added 18.79%
13,832 $570,000
Q4 2023

Feb 14, 2024
BUY
$14.19 - $42.33 $165,228 - $492,890
11,644 New
11,644 $479,000
Q2 2023

Aug 10, 2023
BUY
$21.73 - $31.43 $9,213 - $13,326
424 Added 4.5%
9,842 $244,000
Q1 2023

May 11, 2023
SELL
$26.15 - $37.26 $32,504 - $46,314
-1,243 Reduced 11.66%
9,418 $257,000
Q4 2022

Feb 02, 2023
BUY
$32.47 - $57.24 $26,722 - $47,108
823 Added 8.37%
10,661 $364,000
Q3 2022

Nov 04, 2022
BUY
$41.87 - $57.99 $9,755 - $13,511
233 Added 2.43%
9,838 $437,000
Q2 2022

Aug 01, 2022
SELL
$36.01 - $74.24 $169,967 - $350,412
-4,720 Reduced 32.95%
9,605 $404,000
Q1 2022

May 10, 2022
SELL
$60.27 - $81.57 $205,882 - $278,643
-3,416 Reduced 19.25%
14,325 $964,000
Q4 2021

Feb 08, 2022
BUY
$65.85 - $96.21 $107,993 - $157,784
1,640 Added 10.19%
17,741 $1.46 Million
Q3 2021

Nov 12, 2021
SELL
$73.2 - $107.87 $294,556 - $434,068
-4,024 Reduced 20.0%
16,101 $1.32 Million
Q2 2021

Aug 13, 2021
BUY
$60.45 - $84.26 $234,546 - $326,928
3,880 Added 23.88%
20,125 $1.55 Million
Q1 2021

May 14, 2021
BUY
$58.19 - $91.37 $135,931 - $213,440
2,336 Added 16.79%
16,245 $1.07 Million
Q4 2020

Feb 09, 2021
BUY
$20.19 - $84.93 $80,961 - $340,569
4,010 Added 40.51%
13,909 $1.18 Million
Q3 2020

Nov 13, 2020
SELL
$22.99 - $36.34 $7,609 - $12,028
-331 Reduced 3.24%
9,899 $234,000
Q2 2020

Aug 03, 2020
BUY
$29.88 - $56.74 $108,105 - $205,285
3,618 Added 54.72%
10,230 $343,000
Q1 2020

May 15, 2020
SELL
$33.0 - $54.5 $154,803 - $255,659
-4,691 Reduced 41.5%
6,612 $266,000
Q4 2019

Feb 12, 2020
BUY
$15.39 - $44.38 $173,953 - $501,627
11,303 New
11,303 $464,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email